Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
SN Compr Clin Med ; 3(12): 2629-2634, 2021.
Article in English | MEDLINE | ID: covidwho-1465972

ABSTRACT

As the second wave of COVID-19 disease is gripping the globe, liver transplant centers are increasingly receiving patients recovered from SARS-CoV-2 infection in recent few weeks. Unexpected complications in these patients are increasingly being recognized. We performed liver transplantation on a 51-year-old gentleman with decompensated liver disease 23 days after recovering from a mild SARS-CoV-2 infection. Surprisingly, despite massive blood loss and a prolonged anhepatic phase, his thromboelastographic (TEG) parameters persistently revealed hypercoagulability. After a brief uneventful early post-operative period, he developed hepatic arterial thrombosis on the 14th post-operative day, and again after 4 days, both of which required surgical intervention. Following discharge, the artery was thrombosed again which was only picked up when he developed a cholangiolar abscess, leading to graft loss necessitating re-transplantation. There is a lot of evidence suggesting that patients with SARS-CoV-2 infection tend to be hypercoagulable. We believe that this hypercoagulability might have played a significant role in the development of hepatic arterial thrombosis and eventual graft loss in this patient. This highlights the importance of revisiting anticoagulation protocols in liver transplant recipients recovered from COVID-19 and base them on TEG rather than routine parameters such as INR and APTT, which are routinely deranged in such patients.

2.
Braz J Anesthesiol ; 71(5): 576-578, 2021.
Article in English | MEDLINE | ID: covidwho-1293601

ABSTRACT

A primigravida at 32 weeks of gestation presented to us with eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES) along with SARS COVID-19 pneumonia. Immediate termination of pregnancy was done under general anesthesia and patient was electively ventilated in view of increased oxygen requirements. Further therapy using magnesium sulphate, antihypertensives, steroids, and convalescent plasma was carried out. The condition of the patient steadily improved leading to her extubation on the 4th postoperative day and subsequent discharge on the 8th day of admission.


Subject(s)
COVID-19/complications , Eclampsia/diagnosis , Posterior Leukoencephalopathy Syndrome/diagnosis , Pregnancy Complications, Infectious/diagnosis , Adult , COVID-19/diagnosis , Eclampsia/therapy , Female , Humans , Pneumonia, Viral/diagnosis , Pneumonia, Viral/virology , Posterior Leukoencephalopathy Syndrome/therapy , Pregnancy , Pregnancy Complications, Infectious/therapy , Pregnancy Outcome
SELECTION OF CITATIONS
SEARCH DETAIL